177 related articles for article (PubMed ID: 23314854)
1. Thrombocytosis and hepatocellular carcinoma.
Carr BI; Guerra V
Dig Dis Sci; 2013 Jun; 58(6):1790-6. PubMed ID: 23314854
[TBL] [Abstract][Full Text] [Related]
2. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
[TBL] [Abstract][Full Text] [Related]
4. HCC and its microenvironment.
Carr BI; Guerra V
Hepatogastroenterology; 2013 Sep; 60(126):1433-7. PubMed ID: 23933936
[TBL] [Abstract][Full Text] [Related]
5. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
6. High platelet count as a poor prognostic factor for liver cancer patients without cirrhosis.
Midorikawa Y; Takayama T; Higaki T; Aramaki O; Teramoto K; Yoshida N; Tsuji S; Kanda T; Moriyama M
Biosci Trends; 2020 Nov; 14(5):368-375. PubMed ID: 32713867
[TBL] [Abstract][Full Text] [Related]
7. Features of massive hepatocellular carcinomas.
Carr BI; Guerra V
Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):101-8. PubMed ID: 23863262
[TBL] [Abstract][Full Text] [Related]
8. Thrombocytosis is associated with worse survival in patients with hepatocellular carcinoma.
Liu PH; Hsu CY; Su CW; Huang YH; Hou MC; Rich NE; Fujiwara N; Hoshida Y; Singal AG; Huo TI
Liver Int; 2020 Oct; 40(10):2522-2534. PubMed ID: 32511831
[TBL] [Abstract][Full Text] [Related]
9. Hepatoblastoma, thrombocytosis, and increased thrombopoietin.
Nickerson HJ; Silberman TL; McDonald TP
Cancer; 1980 Jan; 45(2):315-7. PubMed ID: 6153151
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
11. Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.
Lim C; Compagnon P; Sebagh M; Salloum C; Calderaro J; Luciani A; Pascal G; Laurent A; Levesque E; Maggi U; Feray C; Cherqui D; Castaing D; Azoulay D
HPB (Oxford); 2015 Jul; 17(7):611-23. PubMed ID: 25980326
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.
Carr BI; Guerra V
Oncology; 2013; 85(3):153-9. PubMed ID: 23988857
[TBL] [Abstract][Full Text] [Related]
14. King's score as a novel prognostic model for patients with hepatitis B-associated hepatocellular carcinoma.
Pang Q; Bi JB; Xu XS; Liu SS; Zhang JY; Zhou YY; Qu K; Liu C
Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1337-46. PubMed ID: 26275082
[TBL] [Abstract][Full Text] [Related]
15. [A case of hepatocellular carcinoma with paraneoplastic hypercholesterolemia, thrombocytosis and hypoglycemia].
Inomata E; Sohda T; Nakane H; Morihara D; Hirose O; Kitamura Y; Iwata K; Irie M; Takeyama Y; Watanabe H; Sakisaka S
Nihon Shokakibyo Gakkai Zasshi; 2007 Aug; 104(8):1231-5. PubMed ID: 17675826
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
Han XJ; Su HY; Shao HB; Xu K
World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
[TBL] [Abstract][Full Text] [Related]
17. No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.
Alkozai EM; Porte RJ; Adelmeijer J; Zanetto A; Simioni P; Senzolo M; Lisman T
Thromb Res; 2015 Feb; 135(2):292-7. PubMed ID: 25434630
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients.
Ülger Y; Delik A
Eur J Gastroenterol Hepatol; 2022 Jul; 34(7):769-773. PubMed ID: 34974464
[TBL] [Abstract][Full Text] [Related]
20. Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals.
Casadei Gardini A; Foschi FG; Conti F; Petracci E; Vukotic R; Marisi G; Buonfiglioli F; Vitale G; Ravaioli F; Gitto S; Verucchi G; Lenzi M; Bolondi L; Mazzella G; Brillanti S; Andreone P;
Dig Liver Dis; 2019 May; 51(5):681-688. PubMed ID: 30327251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]